Data as of Dec 19
| -0.33 / -17.10%|
The 2 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 8.50, with a high estimate of 9.00 and a low estimate of 8.00. The median estimate represents a +431.25% increase from the last price of 1.60.
The current consensus among 2 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.